Stay updated on Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page.

Latest updates to the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision tag on the study page was updated from v3.6.4 to v3.6.5, indicating a minor publication/version update. This change does not modify study details, eligibility criteria, outcomes, or other user-facing content.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.6.4 is now shown, replacing the previous Revision: v3.6.3, which indicates a minor internal update to the page template or documentation.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing Revision: v3.6.2, updating the study record's version metadata.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page revision tag changed from v3.6.0 to v3.6.2, indicating a new page build. This likely represents maintenance or a small fix to the study details page rather than a content update.SummaryDifference0.0%

- Check63 days agoChange DetectedThe study record page now includes new navigation/help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and the heading for 'Intervention/Treatment' has replaced the old 'Intervention / Treatment' label with a new 'Revision: v3.6.0'. It also displays 'No longer looking for participants', indicating the study is not currently enrolling.SummaryDifference0.3%

- Check70 days agoChange DetectedThe revision label in the study documents area was updated from v3.5.4 to v3.5.5, indicating a newer version of the document.SummaryDifference0.0%

Stay in the know with updates to Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib & Pembrolizumab in TNBC & Ovarian Cancer Clinical Trial page.